SE465206B - Farmaceutisk beredning foer bekaempning av patogena tarmbakterier - Google Patents

Farmaceutisk beredning foer bekaempning av patogena tarmbakterier

Info

Publication number
SE465206B
SE465206B SE8904332A SE8904332A SE465206B SE 465206 B SE465206 B SE 465206B SE 8904332 A SE8904332 A SE 8904332A SE 8904332 A SE8904332 A SE 8904332A SE 465206 B SE465206 B SE 465206B
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparation
preparation according
strain
pharmaceutically acceptable
acceptable carrier
Prior art date
Application number
SE8904332A
Other languages
English (en)
Swedish (sv)
Other versions
SE8904332L (sv
SE8904332D0 (sv
Inventor
Eva Grahn
Stig Holm
Original Assignee
Eva Grahn
Stig Holm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eva Grahn, Stig Holm filed Critical Eva Grahn
Priority to SE8904332A priority Critical patent/SE465206B/sv
Publication of SE8904332D0 publication Critical patent/SE8904332D0/xx
Priority to US07/861,796 priority patent/US5322686A/en
Priority to ES91901938T priority patent/ES2084806T3/es
Priority to DE69025953T priority patent/DE69025953T2/de
Priority to PCT/SE1990/000850 priority patent/WO1991009608A1/en
Priority to JP03502116A priority patent/JP3140049B2/ja
Priority to EP91901938A priority patent/EP0506817B1/en
Priority to DK91901938.0T priority patent/DK0506817T3/da
Priority to AU70482/91A priority patent/AU641722B2/en
Priority to AT91901938T priority patent/ATE135228T1/de
Priority to CA002070687A priority patent/CA2070687C/en
Publication of SE8904332L publication Critical patent/SE8904332L/xx
Publication of SE465206B publication Critical patent/SE465206B/sv
Priority to FI922825A priority patent/FI96744C/fi
Priority to NO922379A priority patent/NO303620B1/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56—Platinum group metals
    • B01J23/62—Platinum group metals with gallium, indium, thallium, germanium, tin or lead
    • B01J23/622—Platinum group metals with gallium, indium, thallium, germanium, tin or lead with germanium, tin or lead
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/06—Halogens; Compounds thereof
    • B01J27/08—Halides
    • B01J27/10—Chlorides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/22—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by isomerisation
    • C07C5/2206—Catalytic processes not covered by C07C5/23 - C07C5/31
    • C07C5/226—Catalytic processes not covered by C07C5/23 - C07C5/31 with metals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2521/00—Catalysts comprising the elements, oxides or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium or hafnium
    • C07C2521/02—Boron or aluminium; Oxides or hydroxides thereof
    • C07C2521/04—Alumina
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/14—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of germanium, tin or lead
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
    • C07C2523/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals of the platinum group metals
    • C07C2523/42—Platinum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
    • C07C2523/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals combined with metals, oxides or hydroxides provided for in groups C07C2523/02 - C07C2523/36
    • C07C2523/56—Platinum group metals
    • C07C2523/62—Platinum group metals with gallium, indium, thallium, germanium, tin or lead
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE8904332A 1989-12-22 1989-12-22 Farmaceutisk beredning foer bekaempning av patogena tarmbakterier SE465206B (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE8904332A SE465206B (sv) 1989-12-22 1989-12-22 Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
CA002070687A CA2070687C (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
EP91901938A EP0506817B1 (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
AU70482/91A AU641722B2 (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
DE69025953T DE69025953T2 (de) 1989-12-22 1990-12-19 Pharmazeutische zubereitung zur kontrolle pathogener intestinaler bakterien
PCT/SE1990/000850 WO1991009608A1 (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
JP03502116A JP3140049B2 (ja) 1989-12-22 1990-12-19 病原性腸内細菌をコントロールするための医薬製剤
US07/861,796 US5322686A (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
DK91901938.0T DK0506817T3 (da) 1989-12-22 1990-12-19 Farmaceutisk præparat til kontrol med patogene intestinale bakterier
ES91901938T ES2084806T3 (es) 1989-12-22 1990-12-19 Preparacion farmaceutica para el control de bacterias intestinales patogenas.
AT91901938T ATE135228T1 (de) 1989-12-22 1990-12-19 Pharmazeutische zubereitung zur kontrolle pathogener intestinaler bakterien
NO922379A NO303620B1 (no) 1989-12-22 1992-06-17 FremgangsmÕte for fremstilling av et farmas°ytisk preparat for bekjempelse av patogene mikroorganismer i mennesker og dyr
FI922825A FI96744C (fi) 1989-12-22 1992-06-17 Menetelmä farmaseuttisen valmisteen valmistamiseksi patogeenisten suolistobakteerien torjumiseksi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904332A SE465206B (sv) 1989-12-22 1989-12-22 Farmaceutisk beredning foer bekaempning av patogena tarmbakterier

Publications (3)

Publication Number Publication Date
SE8904332D0 SE8904332D0 (sv) 1989-12-22
SE8904332L SE8904332L (sv) 1991-06-23
SE465206B true SE465206B (sv) 1991-08-12

Family

ID=20377846

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8904332A SE465206B (sv) 1989-12-22 1989-12-22 Farmaceutisk beredning foer bekaempning av patogena tarmbakterier

Country Status (13)

Country Link
US (1) US5322686A (fi)
EP (1) EP0506817B1 (fi)
JP (1) JP3140049B2 (fi)
AT (1) ATE135228T1 (fi)
AU (1) AU641722B2 (fi)
CA (1) CA2070687C (fi)
DE (1) DE69025953T2 (fi)
DK (1) DK0506817T3 (fi)
ES (1) ES2084806T3 (fi)
FI (1) FI96744C (fi)
NO (1) NO303620B1 (fi)
SE (1) SE465206B (fi)
WO (1) WO1991009608A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705152A (en) * 1990-10-26 1998-01-06 Interprise Limited Antimicrobial composition
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
US5478557A (en) * 1992-07-29 1995-12-26 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5714378A (en) 1995-03-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Navy Pseudomonas chlororaphis microorganism polyurethane degrading enzyme obtained therefrom and method of using enzyme
AT405235B (de) * 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
GR1002668B (el) * 1996-03-15 1997-04-14 N Μεθοδος προσθηκης στειρου αεριου αζωτου και φαρμακολογικως δραστικων ουσιων εις στερεο γιαουρτι.
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
CA2414941C (en) 2000-08-11 2010-12-14 David R. Whitlock Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
WO2003057380A2 (en) * 2002-01-11 2003-07-17 Whitlock David R Compositions including ammonia oxidizing bacteria and methods of using same
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8877178B2 (en) * 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
FR2883131B1 (fr) * 2005-03-16 2007-04-27 Sarl Caribou T G Sarl Procede de preparation de grains de kefir, et application aux installations de preparation de soupes pour animaux d'elevage
AU2006253006B8 (en) * 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
AU2006253007B2 (en) * 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
JP5799299B2 (ja) 2007-02-01 2015-10-21 ザ・アイムス・カンパニーＴｈｅ Ｉａｍｓ Ｃｏｍｐａｎｙ ブドウ糖代謝拮抗物質、アボカド又はアボカド抽出物を使用する、哺乳動物における炎症及びストレスの低下方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
WO2010056198A1 (en) 2008-11-17 2010-05-20 Essum Ab Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
KR20230165365A (ko) 2014-04-15 2023-12-05 에이오바이오미 엘엘씨 암모니아-산화 니트로소모나스 유트로파 균주 d23

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1190386A (en) * 1966-06-28 1970-05-06 Green Cross Corp Process for producing the Lactic Acid Bacteria Drugs
SU1333709A1 (ru) * 1985-11-29 1987-08-30 Всесоюзный Научно-Исследовательский Институт Молочной Промышленности Штамм SтRертососсUS LастIS,используемый в заквасках дл приготовлени кисломолочных продуктов
JPS62201823A (ja) * 1986-02-28 1987-09-05 Freunt Ind Co Ltd 腸内有用細菌含有物およびその製造方法
SU1423586A1 (ru) * 1986-06-09 1988-09-15 Институт Микробиологии И Вирусологии Ан Казсср Способ приготовлени закваски "Казахсил" дл силосовани кормов
US5143845A (en) * 1986-09-03 1992-09-01 Toa Pharmaceutical Co., Ltd. Mixture of saccarifying lactic acid producing and butyric acid producing bacteria
JP2612001B2 (ja) * 1987-09-04 1997-05-21 フロイント産業株式会社 腸内有用細菌含有顆粒およびその製造方法
AU4055689A (en) * 1988-08-03 1990-03-05 Wisconsin Alumni Research Foundation Biological inoculant effective against aphanomyces

Also Published As

Publication number Publication date
US5322686A (en) 1994-06-21
DE69025953D1 (de) 1996-04-18
NO303620B1 (no) 1998-08-10
ES2084806T3 (es) 1996-05-16
ATE135228T1 (de) 1996-03-15
JP3140049B2 (ja) 2001-03-05
NO922379L (no) 1992-08-12
EP0506817A1 (en) 1992-10-07
SE8904332L (sv) 1991-06-23
EP0506817B1 (en) 1996-03-13
AU7048291A (en) 1991-07-24
CA2070687C (en) 2001-04-10
CA2070687A1 (en) 1991-06-23
FI922825A0 (fi) 1992-06-17
NO922379D0 (no) 1992-06-17
WO1991009608A1 (en) 1991-07-11
AU641722B2 (en) 1993-09-30
SE8904332D0 (sv) 1989-12-22
FI96744B (fi) 1996-05-15
FI96744C (fi) 1996-08-26
JPH05502873A (ja) 1993-05-20
DE69025953T2 (de) 1996-09-05
DK0506817T3 (da) 1996-04-15
FI922825A (fi) 1992-06-17

Similar Documents

Publication Publication Date Title
SE465206B (sv) Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
AU693146B2 (en) Probiotic for control of (salmonella)
Balcázar et al. Inhibitory activity of probiotic Bacillus subtilis UTM 126 against Vibrio species confers protection against vibriosis in juvenile shrimp (Litopenaeus vannamei)
US7618640B2 (en) Method and composition for reducing E. coli disease and enhancing performance
Stavric Defined cultures and prospects
Nisbet et al. Maintenance of the biological efficacy in chicks of a cecal competitive-exclusion culture against Salmonella by continuous-flow fermentation
WO2016108538A1 (ko) 신규한 장출혈성 대장균 박테리오파지 Ｅｓｃ-ＣＨＰ-1 및 이의 장출혈성 대장균 증식 억제 용도
KR20010031131A (ko) 돼지의 경쟁적 독점 배양
JP2004523241A (ja) プロバイオティクスとして有用な新規ラクトバチルス・ロイテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）
US10143714B2 (en) In ovo delivery of probiotic cultures
Rimler Studies of the pathogenic avian haemophili
AU662601B2 (en) Probiotic for control of salmonella
KR20040106298A (ko) 불안정한 생활성 물질 및 포유동물 초유를 포함한 조성물,제조 및 치료 방법
EP0801675B1 (en) Saccharomyces treatment to diminish campylobacter and salmonella populations in poultry
CN108179136B (zh) 大肠杆菌噬菌体Esc-COP-9及其致病性大肠杆菌增殖抑制用途
CN117448213B (zh) 一种抑制产气荚膜梭菌的植物乳杆菌及其后生元和应用
KR101643235B1 (ko) 황색포도상구균에 대해 숙주감수성을 나타내는 박테리오파지 시포비리데 패밀리 sap4 및 이를 함유하는 조성물
US5302388A (en) Control of campylobacter jejuni colonization
KR100371503B1 (ko) 양식어류의 사료첨가제용 미생물 제제 및 그 제조방법
KR101796642B1 (ko) 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-9 및 이의 병원성 대장균 증식 억제 용도
US9107938B2 (en) Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
KR101830900B1 (ko) 신규한 조류 병원성 대장균 특이 박테리오파지 ec13 및 이를 포함하는 항균 조성물
KR20230125654A (ko) 신규한 페디오코커스 펜토사세우스 균주 및 이를 포함하는 돼지 설사증 예방 또는 개선용 조성물
Promsopone et al. Evaluation of an avian-specific probiotic and Salmonella typhimurium-specific antibodies on the colonization of Salmonella typhimurium in broilers
WO1998047521A1 (en) Phages, methods for growing and detecting them and their use

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8904332-7

Format of ref document f/p: F